XXSYS TECHNOLOGIES INC /CA
10QSB/A, 1996-07-15
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: XXSYS TECHNOLOGIES INC /CA, 10KSB/A, 1996-07-15
Next: XXSYS TECHNOLOGIES INC /CA, 10QSB/A, 1996-07-15



<PAGE>   1
                UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                  FORM 10-QSB/A

                QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                         -------------------------------

                For the quarterly period ended December 31, 1995


                         Commission File Number: 0-20376

                            XXSYS TECHNOLOGIES, INC.
        (Exact name of small business issuer as specified in its charter)

            California                                           33-0161808
  (State or other jurisdiction of                             (I.R.S. Employer
   incorporation or organization)                            Identification No.)

                              4619 Viewridge Avenue
                           San Diego, California 92123
                    (Address of principal executive offices)

                                 (619) 974-8200
                           (Issuer's telephone number)

         Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. 
Yes X No

         State the number of shares outstanding of each of the issuer's classes
of common equity, as of the latest practicable date: Common Stock, no par value
- -- 6,149,057 shares outstanding on February 13, 1996.

Transitional Small Business Disclosure Format (check one): Yes X No
<PAGE>   2
                            XXSYS TECHNOLOGIES, INC.

                                      INDEX

                         PART I -- FINANCIAL INFORMATION

<TABLE>
<CAPTION>
                                                                           PAGE
                                                                           ----
<S>                                                                        <C>
         Condensed Consolidated Balance Sheets                             3

         Condensed Consolidated Statements of Operations                   4

         Condensed Consolidated Statements of Cash Flows                   5

         Notes to Consolidated Financial Statements                        6-8
</TABLE>

                                       2
<PAGE>   3
                            XXSYS TECHNOLOGIES, INC.

                           CONSOLIDATED BALANCE SHEETS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                             DECEMBER 31,      SEPTEMBER 30,
ASSETS                                                           1995              1995
                                                             ------------      ------------
<S>                                                          <C>               <C>         
Current Assets:
    Cash and cash equivalents                                $    884,542      $    148,562
    Accounts receivable                                           176,743            46,623
    Stock subscription receivable                                    --             380,000
    Inventory                                                        --                --
    Prepaid expenses and other                                     79,089            53,600
                                                             ------------      ------------
          Total current assets                                  1,140,374           628,785

Machinery, equipment and furniture, net of
   accumulated depreciation of  $365,434 and $ 207,211            571,648           439,047

Long-term note receivable                                         446,928           446,928

Deferred costs (Note 2)                                           192,500         1,102,181

Patents, net of amortization of $94,776 and $86,298                71,857            59,796
                                                             ------------      ------------
                                                             $  2,423,307      $  2,676,737
                                                             ============      ============

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
    Notes payable                                            $    502,552      $    695,552
    Accounts payable                                              434,587           521,699
    Accrued liabilities                                           307,360            98,622
    Related party accrued expenses                                193,905           192,426
                                                             ------------      ------------
            Total current liabilities                           1,438,404         1,508,299

Commitments and contingencies

Stockholders' equity:
    Preferred stock, par value $100
        Shares authorized -- 2,000,000;
        Issued and outstanding -- 4,500
        (liquidation preference -- $450,000)                      450,000           450,000
    Common stock, no par value
        Shares authorized  -- 20,000,000;
        Issued and outstanding  -- 6,142,822 / 6,067,082       12,216,228        12,068,535
Accumulated deficit                                           (11,230,286)      (10,910,399)
Note receivable for preferred stock                              (275,039)         (263,698)
Note receivable for common stock                                 (176,000)         (176,000)
Deferred compensation                                                --                --
                                                             ------------      ------------
          Total stockholders' equity                              984,903         1,168,438
                                                             ------------      ------------
                                                             $  2,423,307      $  2,676,737
                                                             ============      ============
</TABLE>

                             See accompanying notes.

                                       3
<PAGE>   4
                           XXSYS TECHNOLOGIES, INC.

                      CONSOLIDATED STATEMENTS OF OPERATIONS

                                   (Unaudited)

<TABLE>
<CAPTION>
                                                 THREE MONTHS ENDED DECEMBER 31,
                                                     1995              1994
                                                  -----------       ----------- 
<S>                                               <C>               <C>      
Revenues:
    Sales                                         $      --         $      --
    Contract revenues                                 188,000           118,713
                                                  -----------       ----------- 
         Total revenues                               188,000           118,713

Operating expenses:
    Cost of equipment                                    --                --
    Cost of services                                  124,302             1,632
    Selling, general and administrative               513,100           206,765
    Research and development                             --              14,193
                                                  -----------       ----------- 
         Total operating expenses                     637,402           222,590

Operating loss                                       (449,402)         (103,877)

Interest income                                        27,253            12,239
Other income (6)                                      122,820              --
Interest expense                                      (20,558)          (18,679)
                                                  -----------       ----------- 
Net loss                                          $  (319,887)      $  (110,317)
                                                  ===========       ===========
Net loss per share                                $      (.05)      $      (.03)
                                                  ===========       ===========
Weighted average number of shares
outstanding                                         6,077,784         4,267,898
                                                  ===========       ===========
</TABLE>

                             See accompanying notes.

                                       4
<PAGE>   5
                            XXSYS TECHNOLOGIES, INC.

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                         THREE MONTHS ENDED DECEMBER 31,
                                                              1995             1994
                                                           -----------      ---------
<S>                                                      <C>                <C>       
Cash flows from operating activities:
    Net loss                                               $  (319,887)     $(110,317)
    Adjustments to reconcile net loss to cash
        used in operating activities:
        Depreciation and amortization                           33,902         28,293
        Non-cash compensation                                     --           10,000
        Accrued interest income                                (11,341)       (11,343)
        Changes in assets and liabilities:
            Investments                                           --             --
            Accounts receivable                               (130,120)         3,896
            Inventories                                           --             --
            Prepaid expenses and other                         (25,489)           672
            Accounts payable                                   (87,112)       (56,523)
            Accrued liabilities                                 58,738         56,999
            Related party accrued expenses                       1,479          5,992
                                                           -----------      ---------
                 Net cash used in operating activities        (479,830)       (72,331)

Cash flows from investing activities:
    Purchase of machinery and equipment                       (158,685)       (66,610)
    Deferred acquisition costs                               1,102,181         (1,991)
    Other assets                                               (19,879)       (74,101)
                                                           -----------      ---------
         Net cash used in investing activities                 923,617       (142,702)

Cash flows from financing activities:
    Sale of common stock                                       380,000           --
    Warrant redemption costs                                   (42,500)          --
    Exercise of warrants                                       147,693           --
    Issuance of convertible notes                                 --          800,000
    Issuance of other notes payable                               --             --
    Repayment of notes payable                                (193,000)          --
    Payments of related party debt                                --
                                                           -----------      ---------
        Net cash from financing activities                     292,193        800,000
Net increase (decrease) in cash                                735,980        584,967
Cash and cash equivalents -- beginning of period               148,562          8,722
                                                           -----------      ---------
Cash and cash equivalents at end of period                 $   884,542      $ 593,689
                                                           ===========      =========
</TABLE>

                             See accompanying notes.

                                       5
<PAGE>   6
                            XXSYS TECHNOLOGIES, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. BASIS OF PRESENTATION

         The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with generally accepted accounting principles
and reflect, in the opinion of management, all adjustments necessary for a fair
presentation of the information contained therein. The condensed consolidated
financial statements should be read in conjunction with the consolidated
financial statements and notes for the year ended September 30, 1995, contained
in the Company's Form 10-K. The results of operations for the three-month period
ended December 31, 1995, are not necessarily indicative of results for the
entire year.

2. DEFERRED COSTS

         Costs incurred in the first quarter ended December 31, 1995, are in
connection with a planned redemption of warrants and have been deferred. If the
warrant redemption is completed, these costs will be accounted for as part of
the cost of the redemption. Otherwise, they will be charged to expense in the
period the warrant redemption activity is terminated.

         Costs incurred for the period ended September 30, 1995, were in
connection with a proposed acquisition, which was terminated subsequent to
September 30, 1995. The Company received a cash settlement when it released
certain parties to a lawsuit filed by the Company in October 1995 related to
this matter. (See Note 6, Other Income.)

3. NOTES PAYABLE

         Notes payable borrowed from four individuals in May 1994 totaling
$100,000 and having an interest rate of 10% per year were paid off on October 4,
1995, including $13,940 in interest. Another note payable of $93,000 borrowed
from an individual over the August-September 1995 time-frame having an interest
rate of 10% per year was repaid on December 4,1995, including $4,904 in
interest.

         Notes payable at December 31, 1995 totaling $502,552 represent
extensions and additions to loans that were in existence from two parties prior
to October 1, 1995. The interest rate on loans outstanding at December 31, 1995,
is at 10% per year. These notes payable are due on October 11, 1996, or upon the
Company receiving no less than $2 million from any equity offering, whichever
occurs sooner. Based on management's current plans for repayment, these new
notes are recorded as short term liabilities.

4. COMMITMENTS

         At December 31, 1995, the Company had a commitment to purchase a column
wrapping machine at a cost of approximately $312,000, of which $210,413 had been
paid.

5. STOCKHOLDERS' EQUITY

Common Stock:

         On December 27, 1995, the Company received $147,693 upon the exercise
of a warrant to purchase 75,740 restricted shares of common stock at $1.95 per
share.

         On October 3, 1995, the Company received cash in the amount of $380,000
as part of a subscription receivable related to a private placement of
$1,056,000, in exchange for 211,200 shares of common stock sold to an uncle of
the Company's chairman at a price of $5.00 per share under a purchase agreement
dated September 1, 1995. Cash in the amount of $500,000 had already been
received by September 30, 1995. Of the total purchase commitment, $176,000
remains as a two-year note payable to the Company at an interest rate of 10% per
year, due September 29, 1997.

                                       6
<PAGE>   7
6. OTHER INCOME

         Other income of $122,820 represents the net effect of the Company's
settlement of a lawsuit in which it claimed breach of contract and breach of
fiduciary relationship against third parties who interfered with Company's
efforts to acquire a composite materials company (the "target company"). As
part of the settlement, the Company received a cash payment of $1,300,000, which
has been offset against the Company's cost of acquisition, including legal fees,
appraisal, environmental studies and other due diligence costs and estimated
charges for future costs totaling $1,177,180.

         In November 1995 a claim for fees in connection with the Company's
attempted acquisition of the target company was placed against the Company by
its previous investment banker, H. J. Meyers & Co., Inc. ("HJM") (formerly
Thomas James Associates, Inc.). HJM claims that the Company's aforementioned
settlement with the purchaser of the target company qualifies as a "Transaction"
under the terms of the Company's earlier investment banking agreement with HJM,
and that HJM is entitled to an investment banking fee. HJM is seeking $400,000
as its share of the Company's settlement and is willing to waive its right of
first refusal to be the Underwriter of a warrant redemption as a part of that
settlement amount. The Company denies the settlement with purchaser represents a
Transaction and is disputing HJM's claim. Further, the Company plans to go
forward with the warrant redemption as planned, but without an Underwriter (See
Liquidity and Capital Resources).

RESULTS OF OPERATIONS

First Quarter of 1996 Compared to First Quarter of 1995

         Revenues of $188,000 were recorded in the quarter ended December 31,
1995, the first quarter of the Company's 1995 fiscal year, representing an
increase of $69,287, or 58%, over the first quarter of fiscal 1994. The increase
in revenues was due principally to billings under government contracts which
fund the validation and resting of the Robo-Wrapper(TM) technology.

         Total operating expenses of $637,402 in the first quarter 1996
increased by $414,812, or 186%, over the first quarter of fiscal 1995. The cost
of services of $124,302 represented 66% of contract revenues in the first
quarter 1996. Research and development efforts for the first quarter 1996 were
all part of billable government contracts and therefore were reported as cost of
services. Selling, general and administrative expenses increased by $ 306,335,
or 148%, to $513,100, as the result of higher staffing levels and travel
activity.

         Interest income during the first quarter increased to $27,253, compared
to $12,239 in the prior year's first quarter, as a result of a higher level of
cash available for investment and accrued interest on the long term note
receivable. Other income was the result of a settlement of a lawsuit (see Note
6, Other Income).

         The net loss for the first quarter of fiscal 1996 of $319,887
represents an increase of $209,570, or 190%, over the net loss of $110,317 in
the first quarter of 1995. On a per share basis, the net loss was $0.05 in the
first quarter 1996, compared to $0.03 in the first quarter of 1995.

LIQUIDITY AND CAPITAL RESOURCES--PLANNED WARRANT REDEMPTION

         On January 16, 1996, the Company announced that it plans to call for
redemption of its publicly-traded common stock warrants ("Warrants"). The
Company has a right to redeem the Warrants at $0.05 per Warrant. There are
1,600,000 Warrants issued and outstanding, each of which entitles the holder to
purchase one share of common stock of the Company. The initial exercise price of
the Warrants was $6.00 per share, however, the exercise price at the time of the
call for redemption is expected to be closer to $4.00 per share after giving
effect to certain adjustments pursuant to the anti-dilution provisions of the
Warrants.

         The anti-dilution provision also affects the number of shares to be
purchased at the lower price, such that each Warrant is expected to entitle the
holder to purchase 1.50 shares of common stock (at $4.00 per share). The Company
expects to formally call the Warrants for redemption in the early Spring of
1996, subject to the effectiveness of a registration statement to be filed with
the Securities and Exchange Commission for purposes of registering the shares of
common stock issuable upon exercise of the Warrants.

                                       7
<PAGE>   8
         The redemption of the Warrants, and the sale of any shares of common
stock issued upon the exercise of the Warrants, shall be made only by means of a
prospectus made part of the registration statement to be filed with the
Securities and Exchange Commission.

IMPACT OF INFLATION

         Inflation has not had any significant effect on the Company's operating
costs.

                          PART II -- OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

         The Company is currently subject to certain claims and legal actions
arising in the ordinary course of its business. In the opinion of management,
all such matters are adequately covered by insurance or will not have a material
adverse effect on the Company's financial position.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.

(a)      Exhibits:

         None

(b)      Reports on Form 8-K:

         On October 10, 1995, the Company filed a Form 8-K relating to the
settlement of a lawsuit that it filed against third parties in which the Company
claimed breach of contract and fiduciary duty with regard to its efforts to
acquire a carbon composites manufacturer.

                                       8
<PAGE>   9
                                   SIGNATURES

         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                          XXSYS TECHNOLOGIES, INC.

 July 9, 1996
                                          By: /s/ Gregory P. Hanson
                                                  Gregory P. Hanson
                                              Chief Financial Officer (Principal
                                              Financial and Accounting Officer)

                                       9

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM
10-QSB/A FOR THE PERIOD ENDED DECEMBER 31, 1995
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               DEC-31-1995
<EXCHANGE-RATE>                                      1
<CASH>                                         884,542
<SECURITIES>                                         0
<RECEIVABLES>                                  623,671<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,140,374
<PP&E>                                         937,082
<DEPRECIATION>                                 365,434
<TOTAL-ASSETS>                               2,423,307
<CURRENT-LIABILITIES>                        1,438,404
<BONDS>                                              0
                                0
                                    450,000
<COMMON>                                    12,216,226
<OTHER-SE>                                   (451,039)<F2>
<TOTAL-LIABILITY-AND-EQUITY>                 2,423,307
<SALES>                                        188,000
<TOTAL-REVENUES>                               188,000
<CGS>                                          124,302
<TOTAL-COSTS>                                  124,302
<OTHER-EXPENSES>                               513,100
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              20,558
<INCOME-PRETAX>                              (319,887)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (319,887)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (319,887)
<EPS-PRIMARY>                                    (.05)
<EPS-DILUTED>                                        0
<FN>
<F1>INCLUDES LONG TERM NOTE RECEIVABLE OF $446,928 AND TRADE RECEIVABLE OF $176,743
<F2>INCLUDES NOTE RECEIVABLE FOR COMMON STOCK OF $176,000 AND NOTE RECEIVABLE FOR
PREFERRED STOCK OF $275,039 WHICH ARE CONTRA-EQUITY ACCOUNT
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission